Hence, here, we suggested a novel strategy for AKI management using STAT3 inhibitors as the inhibition of STAT3 signaling alleviated the progression of acute kidney injury to chronic kidney disease through anti-apoptosis. The gene discussed is STAT3; the disease is acute kidney injury.